Outcome of patients hospitalized for COVID‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: results of the ACE‐CoV study-Reference-Cited by-同舟云学术

Outcome of patients hospitalized for COVID‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: results of the ACE‐CoV study

Published:2020-10-28 Issue:1 Volume:35 Page:194-203
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Lafaurie Margaux¹²^ORCID,Martin‐Blondel Guillaume³⁴,Delobel Pierre³⁴,Charpentier Sandrine⁵,Sommet Agnès¹²,Moulis Guillaume²⁶^ORCID

Affiliation:

1. Service de Pharmacologie Médicale Faculté de Médecine Centre Hospitalier Universitaire de Toulouse 37 allées Jules Guesde Toulouse31000France

2. Centre d’Investigation Clinique 1436, axe pharmacoépidémiologie Centre Hospitalier Universitaire de Toulouse‐Purpan place du Dr Baylac, TSA40031 Toulouse Cedex 931059France

3. Service des Maladies Infectieuses et Tropicales Centre Hospitalier Universitaire de Toulouse‐Purpan place du Dr Baylac Toulouse Cedex 9TSA4003131059France

4. UMR INSERM/CNRS 1043Centre de Physiopathologie Toulouse Purpan 330 avenue de Grande‐Bretagne Toulouse cedex 931059France

5. Service des Urgences Centre Hospitalier Universitaire de Toulouse Toulouse France

6. Service de Médecine Interne salle Le TallecCentre Hospitalier Universitaire de Toulouse‐Purpan place du Dr Baylac, TSA40031 Toulouse Cedex 931059France

Funder

Université de Toulouse

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12613

Reference37 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization WHO.Coronavirus. Director‐General's opening remarks at the media briefing on COVID ‐ 19‐11 March 2020. Available at:https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. Accessed July 20 2020.

3. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

4. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

5. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of History of Diabetes and Hypertension with Clinical Findings and Length of Hospital Stay in COVID-19 Patients;Middle East Journal of Rehabilitation and Health Studies;2023-12-09

2. COVID-19 and coronary artery disease; A systematic review and meta-analysis;New Microbes and New Infections;2023-06

3. Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic;World Journal of Clinical Cases;2022-09-26

4. Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies;The Egyptian Heart Journal;2022-09-06

5. Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research;Journal of the American Heart Association;2022-06-07